SAN FRANCISCO — As Americans flood online platforms with questions about GLP-1 costs, prescriptions, dosing, and access, , a paid platform connecting people with verified human experts for on-demand help, today launched a dedicated weight loss telehealth platform designed to make physician-guided GLP-1 treatment simpler and more affordable for eligible patients. The new direct-to-consumer site () offers access to compounded semaglutide and tirzepatide with transparent monthly pricing, no insurance requirement, and home delivery following review by a licensed U.S.-based physician.
Through the new platform, JustAnswer now offers compounded semaglutide and tirzepatide—medications containing the same active ingredients found in widely prescribed GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound — at transparent, accessible monthly pricing. Pricing starts at $112.49 per month for compounded semaglutide and $195.82 per month for compounded tirzepatide when purchased through an annual plan, with no insurance required.
Interest in GLP-1 weight loss medications has skyrocketed in recent years, with industry reports estimating that more than 1 in 8 U.S. adults have used a GLP-1 drug, driven by growing awareness of their effectiveness for weight management and metabolic health. However, high costs, limited insurance coverage, and access barriers continue to make these medications difficult for many Americans to obtain.
JustAnswer.com Sees 82% YOY Spike in GLP-1 Questions
The launch comes as JustAnswer saw an 82% year-over-year increase in questions about weight loss medications in Q1 2026 compared to Q1 2025, reflecting growing consumer confusion around cost, insurance coverage, prescriptions, dosing, and safe use. In 2026 alone, consumers have submitted approximately 1,900 GLP-1-related questions on JustAnswer, with growth consistent across all three months of Q1, including a 103% year-over-year spike in February.
The data suggests that consumer interest has moved beyond general awareness of GLP-1 medications into a more practical phase: people want to understand whether they qualify, what treatment costs, how prescriptions work, and how to use these medications safely.
Notably, many inquiries on JustAnswer are not focused on side effects or efficacy, but instead reflect practical barriers to access and use. Specifically, the top 5 most common GLP-1-related questions on JustAnswer center on:
- Cost and insurance coverage — for example, “Does insurance typically cover Wegovy or Ozempic for weight loss, and what does it cost without coverage?”
- Dosing and usage instructions — for example, “How do I properly dose Ozempic when starting, and do I need to increase it over time?”
- Prescription access and refills — for example, “Can I get a refill for my Mounjaro prescription online, or do I need to see a doctor again?”
- General usage guidance — for example, “How do I use a weight loss injection pen correctly, and where on the body should I inject it?”
How JustAnswer Weight Loss Pharmacy Works
The new JustAnswer weight loss platform is designed to remove traditional barriers to care with a fast and user-friendly experience:
- Patients complete a brief online medical questionnaire
- A licensed U.S.-based physician reviews the submission
- Most users receive a response within 24 hours
- If approved, medications are shipped directly to the patient’s home at no additional cost
There are no separate consultation fees, and the service does not require insurance, making pricing predictable and transparent.
The platform is designed to support medically appropriate care, not one-size-fits-all prescribing. Each submission is reviewed by a licensed U.S.-based physician, who evaluates eligibility, medical history, potential contraindications, and whether GLP-1 treatment is appropriate for the patient. Patients who are approved receive treatment through licensed U.S. pharmacy partners, with access to guidance throughout the process.
Expanding Access to Modern Healthcare
“The demand for GLP-1 medications has exploded, but the consumer experience is still filled with friction — confusing insurance rules, high out-of-pocket costs, prescription hurdles, and questions about safe use,” said Andy Kurtzig, CEO of JustAnswer. “We built this platform to make medically guided weight loss care more accessible, transparent, and easier to navigate for eligible patients.”
This expansion builds on JustAnswer’s broader mission to democratize access to expert healthcare. Since launching in late 2025, the company has continued to scale its telehealth offerings to meet evolving consumer needs, particularly as patients increasingly seek digital-first healthcare solutions.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release